Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

Add To Watchlist

TSX:TRIL - Post Discussion

Trillium Therapeutics Inc. > OUT - SOLD ON THE GAP UP OPEN

View:

Post by Stockemups on Jan 23, 2020 9:56am

OUT - SOLD ON THE GAP UP OPEN

Whoa, this is a volatile stock.

64

Comment by 88guy88 on Jan 23, 2020 11:34am

smart move.....

30

Comment by Katheryn1 on Jan 23, 2020 11:38am

Not really, just in the last month or so. It did nothing for months. Frankly I think this is a long term hold, 3 or 4 years. I keep accumulating under $3 US and will just hold.

39

Comment by CleverInvestor2 on Jan 23, 2020 3:08pm

Thanks for leaving your profits on the table for me and other longs.

37

Trillium Therapeutics Inc.

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities